# RBAK

## Overview
The RBAK gene encodes the RB-associated KRAB zinc finger protein, a transcriptional regulator that plays a significant role in modulating gene expression. This protein is characterized by the presence of Krüppel-type zinc fingers and a KRAB repressor motif, which are indicative of its involvement in transcriptional regulation and chromatin remodeling. RBAK functions primarily as a coactivator of the androgen receptor (AR), enhancing its transcriptional activity and influencing cellular responses to androgens. Additionally, RBAK interacts with the retinoblastoma protein (Rb), linking AR activity to cell cycle regulation, although its coactivation of AR is independent of Rb. The gene's expression and function have been implicated in various cellular processes, including cell proliferation and differentiation, and it has been associated with clinical outcomes in non-small cell lung cancer (NSCLC) (He2019RBAK; Hofman2003The).

## Function
The RBAK gene encodes a protein that functions as a transcriptional regulator, primarily active in the nucleus of healthy human cells. It interacts with the androgen receptor (AR) and enhances its transcriptional activity, acting as a coactivator. This interaction is crucial for modulating transcriptional responses to androgens, which are important for normal cellular functions regulated by these hormones (Hofman2003The). RBAK is part of a family of transcriptional regulators characterized by Krüppel-type zinc fingers and a KRAB repressor motif, which suggests its involvement in the regulation of cell proliferation and differentiation (Hofman2003The).

RBAK also interacts with the retinoblastoma protein (Rb), linking the androgen receptor to cell cycle regulation. However, its coactivation of AR is independent of Rb, indicating a distinct pathway for enhancing AR activity (Hofman2003The). The protein's role in transcriptional regulation is further supported by its involvement in modulating chromatin structure and recruiting transcriptional repressors, which are essential processes for controlling gene expression (Hofman2003The). These functions highlight RBAK's significance in maintaining normal cellular activities and its potential impact on cell cycle control and differentiation.

## Clinical Significance
The RBAK gene has significant clinical implications in non-small cell lung cancer (NSCLC), a leading cause of cancer-related mortality. Studies have shown that RBAK is upregulated in NSCLC tissues compared to non-tumorous tissues, which correlates with poor disease-free survival in patients (He2019RBAK). This overexpression is associated with enhanced cell migration and invasion, suggesting a role in cancer metastasis (He2019RBAK). Functional assays have demonstrated that knockdown of RBAK in NSCLC cell lines results in reduced cell migration and invasion, highlighting its potential as a therapeutic target (He2019RBAK).

Bioinformatics analyses have identified RBAK's involvement in several cellular processes crucial for cancer progression, including the Wnt signaling pathway, mRNA splicing, protein polyubiquitination, and NF-κB signaling (He2019RBAK). The gene also interacts with key transcription factors such as androgen receptor, forkhead box A1, tumor protein 53, and E2F transcription factors, indicating its role in gene transcription regulation (He2019RBAK). These interactions and pathways underscore the gene's potential impact on NSCLC progression and its value as a prognostic biomarker and therapeutic target (He2019RBAK).

## Interactions
RBAK, a member of the Krüppel zinc finger protein family, interacts with several proteins, notably the androgen receptor (AR) and the retinoblastoma protein (Rb). RBAK interacts with the ligand-binding domain of AR in a ligand-dependent manner, enhancing AR-mediated transcriptional activity. This interaction was identified through yeast two-hybrid screening and confirmed by mammalian two-hybrid experiments, in vitro binding studies, and coimmunoprecipitation (Hofman2003The). RBAK acts as a coactivator of AR, significantly increasing ligand-induced AR activity in mammalian cells, suggesting its role in transcriptional regulation (Hofman2003The).

RBAK also interacts with Rb, influencing E2F-regulated transcription and cell cycle regulation. The interaction with Rb is mediated by the amino-terminal half of RBAK, which may also interact with the N-terminal domain of AR to coactivate its function. However, the coactivation of AR by RBAK is not directly linked to Rb, as evidenced by similar levels of AR coactivation in cells with suppressed Rb function (Hofman2003The). These interactions suggest that RBAK provides a link between androgen receptor activity and cell cycle regulation, potentially affecting cell proliferation through the control of E2F activity by Rb (Hofman2003The).


## References


[1. (He2019RBAK) Bingjun He, Bin Wang, Haiyong Wang, Chu Zhang, Yuanlin Wu, Linhai Fu, and Guangmao Yu. Rbak is upregulated in non‑small cell lung cancer and promotes cell migration and invasion. Experimental and Therapeutic Medicine, August 2019. URL: http://dx.doi.org/10.3892/etm.2019.7900, doi:10.3892/etm.2019.7900. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/etm.2019.7900)

[2. (Hofman2003The) K Hofman, JV Swinnen, F Claessens, G Verhoeven, and W Heyns. The retinoblastoma protein-associated transcription repressor rbak interacts with the androgen receptor and enhances its transcriptional activity. Journal of Molecular Endocrinology, 31(3):583–596, December 2003. URL: http://dx.doi.org/10.1677/jme.0.0310583, doi:10.1677/jme.0.0310583. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1677/jme.0.0310583)